What we've approved

DIR 187

Clinical trial of a genetically modified alphavirus for treatment of cancer

Licence details

Licence number:
DIR 187
Licence status:
Ceased to consider
Category:
Medical
Release:
Limited and controlled
Organisation:

VRT Pharmaceuticals Pty Ltd

Last updated: